Skip to content
Versanis
Science
Our Approach
Areas of Focus
Obesity
Heart Failure in Obesity
Pipeline
Scientific Publications
About Us
Our Focus
Leadership Team
News
Contact
Long-term safety and tolerability of bimagrumab (BYM338) in sporadic inclusion body myositis
